Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
IM Club ApS
APS
Active
CVR 37206547
Egebækvej 98, 2850
Nærum
Other financial service activities, except insurance and pension funding n.e.c.
·
NACE 6499
Est. 2015 · 10 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Other financial service activities, except insurance and pension funding n.e.c.
/
IM Club ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
CL
Casper Lyngbo Hjort
Chief Executive Officer
Chief Executive Officer
2021
Former (2)
LS
Lars Skanvig Bramhelft
Unofficial title
Unofficial title
2021 – 2021
FB
Frans Boch
Management
Management
2015 – 2017
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
INTRAMEDIC HOLDING A/S — 20–24.99%
IM INVEST ApS — 20–24.99%
CARDIOPHARMA ApS — 10–14.99%
Martin Evart — 10–14.99%
Ole Henrik Nielsen — 5–9.99%
Jonas Gardström — 5–9.99%
Kim Schou Andersen — 5–9.99%
Babak Talebinejad — 5–9.99%
Rasmus Hundebøll Bischoff — 5–9.99%
Thomas Francis Beckett — 0%
Jacob Lindberg — 5–9.99%
Sten Drakenberg — 10–14.99%
EDSVIKEN ApS — 10–14.99%
100%
Shareholder
Type
Ownership
Votes
Since
INTRAMEDIC HOLDING A/S
Company
20–24.99%
0%
2022
IM INVEST ApS
Company
20–24.99%
33.33–49.99%
2017
CARDIOPHARMA ApS
Company
10–14.99%
33.33–49.99%
2017
Martin Evart
Individual
10–14.99%
0%
2017
Ole Henrik Nielsen
Individual
5–9.99%
0%
2015
Jonas Gardström
Individual
5–9.99%
0%
2015
Kim Schou Andersen
Individual
5–9.99%
0%
2017
Babak Talebinejad
Individual
5–9.99%
0%
2015
Rasmus Hundebøll Bischoff
Individual
5–9.99%
0%
2015
Thomas Francis Beckett
Individual
0%
5–9.99%
2017
Jacob Lindberg
Individual
5–9.99%
0%
2015
Sten Drakenberg
Individual
10–14.99%
0%
2017
EDSVIKEN ApS
Company
10–14.99%
33.33–49.99%
2016
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on IM Club ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network